Join Jason Stutman , as he unveils:

PROJECT GREENLIGHT

An unprecedented breakthrough that:

  • Unlocks the opportunity to rake in massive payouts of $17,000 or more
  • Six times a month, every month
  • Including a fast-approaching trade that could turn $2,500 into $193,800

Claim your FREE SEAT to watch this event LIVE when you enter your email here now:

Jason Stutman

Investment Director
Project Greenlight

When

1 P.M. EST / 10 A.M. PST
Dave Roberts

Vice President of Media
Angel Publishing

If you’ve ever dreamed of becoming truly wealthy…

Where money doesn’t matter…

And you can do everything you’ve always wanted to do…

Like buy a beach house… pay for your children’s college tuition… or fund a retirement for decades to come…

Then I urge you to join us on for a one-time, special money-making event.

For the first time ever, famed technology expert and Angel investor Jason Stutman has agreed to unveil all the details of his most ambitious project to date.

It’s a wealth-building system that took five years…

57,000 hours of advanced algorithmic programming…

And more than $25 million to create.

It’s called:

Project Greenlight.

And it gives everyday investors an easy way to learn how to set themselves up for massive payouts of $17,000 or more…

At least six times every single month…

Off of the hottest — and most lucrative — market opportunity out there:

The $1.1 trillion biotechnology sector.

As you’ll see in the exclusive summit:

It’s now possible for ANYONE to become a biotech millionaire!

That’s because the unique pattern-matching algorithms at the heart of Project Greenlight can predict…

With as much 95% certainty…

Which biotech stocks are set to explode upwards in value and hand savvy investors a small fortune.

In fact, had you been able to use Project Greenlight yourself during its initial test run of just a few short weeks…

You could right now be $43,360 richer.

Because it would have helped you capture a 669% return on Amarin Corporation…

That in less than 30 days, would have turned $2,500 into $19,220!

Project Greenlight would have also alerted you to the one-week pop of 190% on ProQR Therapeutics…

Which — with the same initial stake — could have handed you a cool $7,250 in easy cash.

And it would have even helped you claim a staggering 3,278% return on Aquinox…

In less than a single day!

That’s enough to turn just $500 into $16,890!

The best part is you don’t have to know the first thing about biology or chemistry…

You don’t have to be a doctor…

You don’t even need a college degree!

All you have to do is tune in to the Project Greenlight Summit on at 1:00 PM.

That’s when Jason will reveal everything about his cutting-edge system.

Things like:

  • The surprising reason Project Greenlight could get a trader at Goldman Sachs fired.
  • The probability “hack” that uses blackjack logic to make biotech trades ultra-profitable.
  • “The Topline Supercharger:” — how one extra step allows you to profit even if the stock price moves DOWN.
  • Jason’s deeply personal reasons for revealing this strategy to the public now.
  • The secretive network of scientists and doctors that have “insider” knowledge about which companies will skyrocket…and how YOU can profit off their expertise.
  • How to recognize a coming FDA “Fast Lane” that can boost the profitability of a drug by tens of millions.
  • And most importantly – the biotech stock being lit up like a Christmas tree AS WE SPEAK – that could net you a 7,650% winner later this month.

With six pinpoint trades delivered every thirty days…

Each with the potential to hand you a $17,000 (or higher) payday…

Project Greenlight could help you learn how to build a seven-figure net worth by the end of 2019.

There’s no question that some people are going to become extremely, ludicrously rich.

The only question is:

Will you be one of them?

Say YES and enter your email here NOW:

You’ll be added to the attendee list and receive alerts right before the event goes live.

I’ll see you at the summit.

To your wealth,

Dave Roberts
Vice President of Media, Angel Publishing